1.
Inoue I, Mukoubayashi C, Yoshimura N, Niwa T, Deguchi H, Watanabe M, Enomoto S, Maekita
T, Ueda K, Iguchi M: Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis:
A population-based case-control study. Int J Cancer 2011, 129(11):2704-2711.
2.
Kim JM, Kim JS, Kim YJ, Oh YK, Kim IY, Chee YJ, Han JS, Jung HC: Conjugated linoleic acids produced by Lactobacillus dissociates IKK-γ and Hsp90 complex
in Helicobacter pylori-infected gastric epithelial cells. Lab Invest 2008, 88(5):541-552.
3.
Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, Potter A, Varro A,
Eibach D, Suerbaum S: Lack of Commensal Flora in Helicobacter pylori-Infected INS-GAS Mice Reduces Gastritis
and Delays Intraepithelial Neoplasia. Gastroenterology 2011, 140(1):210-220.
4.
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF,
Gisbert JP, Graham DY, Rokkas T: Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report. Gut 2012, 61(5):646-664.
5.
Liou JM, Chen CC, Chen MJ, Chen C-C, Chang C-Y, Fang Y-J, Lee JY, Hsu S-J, Luo J-C,
Chang W-H: Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2013, 381(9862):205-213.
6.
Meyer JM, Silliman NP, Wang WJ, Siepman NY, Sugg JE, Morris D, Zhang J, Bhattacharyya
H, King EC, Hopkins RJ: Risk factors for Helicobacter pylori resistance in the United States: the surveillance
of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann intern med 2002, 136(1):13-24.
7.
Zhou QL, Li KM, Jun X, Bo L: Role and functions of beneficial microorganisms in sustainable aquaculture. Bioresource Technol 2009, 100(16):3780-3786.
8.
Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG, Simone CD, Ierardi
E, Leo AD: The Influence of Lactobacillus brevis on Ornithine Decarboxylase Activity and Polyamine
Profiles in Helicobacter pylori-Infected Gastric Mucosa. Helicobacter 2004, 9(2):165-172.
9.
Chen XH, Liu XM, Tian FW, Zhang Q, Zhang Hp, Zhang H, Chen W: Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection
in human gastric epithelial cells. J Food Sci 2012, 77(1):M9-M14.
10.
Sunanliganon C, Thong-Ngam D, Tumwasorn S, Klaikeaw N: Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric
inflammation. World J Gastroentero 2012, 18(20):2472-2480.
11.
Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y: Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori
infection in humans. J Antimicrob Chemoth 2001, 47(5):709-710.
12.
Zaman C, Osaki T, Hanawa T, Yonezawa H, Kurata S, Kamiya S: Analysis of the microflora in the stomach of Mongolian gerbils infected with Helicobacter
pylori. J Gastroen Hepatol 2010, 25(s1):S11-S14.
13.
Thiraworawong T, Spinler JK, Werawatganon D, Klaikeaw N, Venable SF, Versalovic J,
Tumwasorn S: Anti-inflammatory Properties of Gastric-derived Lactobacillus plantarum XB7 in the
Context of Helicobacter pylori Infection. Helicobacter 2014, 19:144-155.
14.
Reddy BS: Prevention of colon cancer by pre-and probiotics: evidence from laboratory studies. Brit J Nutr 1998, 80(4):S219-223.
15.
Lin DC: Probiotics as functional foods. Nutr Clin Pract 2003, 18(6):497-506.
16.
Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC:
The Effects of Probiotics on PPI-Triple Therapy for Helicobacter pylori Eradication. Helicobacter 2008, 13(4):261-268.
17.
Kamiji MM, De Oliveira RB: Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroen Hepat 2005, 17(9):973-981.
18.
Gilliland S, Staley T, Bush L: Importance of Bile Tolerance of Lactobacillus acidophilus Used as a Dietary Adjunct. J Dairy Sci 1984, 67(12):3045-3051.
19.
Hove H, Nørgaard H, Mortensen PB: Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr 1999, 53(5):339-350.
20.
Cotter PD, Hill C: Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol R 2003, 67(3):429-453.
21.
Prasad J, Gill H, Smart J, Gopal PK: Selection and Characterisation of Lactobacillus and Bifidobacterium Strains for Use
as Probiotics. Int Dair J 1998, 8(12):993-1002.
22.
Silva M, Jacobus N, Deneke C, Gorbach S: Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Ch 1987, 31(8):1231-1233.
23.
Engstrand L, Lindberg M: Helicobacter pylori and the gastric microbiota. Best Pract Res Cl Ga 2013, 27(1):39-45.
24.
Hungin APS, Mulligan C, Pot B, Whorwell P, Agreus L, Fracasso P, Lionis C, Mendive
J, de Foy JMP, Rubin G et al: Systematic review: probiotics in the management of lower gastrointestinal symptoms
in clinical practice - an evidence-based international guide. Aliment Pharm Therap 2013, 38(8):864-886.
25.
Winterbourn CC, Vissers MC, Kettle AJ: Myeloperoxidase. Curr Opin Hematol 2000, 7(1):53-58.
26.
Nøorgaard A, Andersen L, Nielsen H: Neutrophil degranulation by Helicobacter pylori proteins. Gut 1995, 36(3):354-357.
27.
Suzuki H, Mori M, Seto K, Kai A, Kawaguchi C, Suzuki M, Suematsu M, Yoneta T, Miura
S, Ishii H: Helicobacter pylori-associated gastric pro-and antioxidant formation in Mongolian
gerbils. Free Radical Bio Med 1999, 26(5):679-684.
28.
Kim JS, Jung HC, Kim JM, Song IS, Kim CY: Helicobacter pylori water-soluble surface proteins activate human neutrophils and
up-regulate expression of CXC chemokines. Digest Dis Sci 2000, 45(1):83-92.
29.
Nazligul Y, Aslan M, Horoz M, Celik Y, Dulger AC, Celik H, Erel O: The effect on serum myeloperoxidase activity and oxidative status of eradication treatment
in patients Helicobacter pylori infected. Clin Biochem 2011, 44(8):647-649.
30.
Liu KY, Du FC, Fu Q, Zhang WJ, Sun HW, Zhang Y, Gan LL, Yue ZY, Zou QM, Guo G: Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for
Helicobacter pylori eradication. Antimicrob Agents Ch 2014, 58(6):3348-3353.
31.
Sherwood MB, de Beer EJ: Discrepancy in analysis of penicillin in blood by the Oxford cup method as revealed
by the paper disc technique. Science 1947, 105:414.
32.
Rokka S, Myllykangas S, Joutsjoki V: Effect of Specific Colostral Antibodies and Selected Lactobacilli on the Adhesion
of Helicobacter pylori on AGS Cells and the Helicobacter-Induced IL-8 Production. Scand J Immunol 2008, 68(3):280-286.
33.
Shmuely H, Burger O, Neeman I, Yahav J, Samra Z, Niv Y, Sharon N, Weiss E, Athamna
A, Tabak M: Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight
constituent of cranberry. Diagn Micr Infec Dis 2004, 50(4):231-235.
34.
Lu JJ, Perng CL, Shyu RY, Chen CH, Lou Q, Chong SK, Lee CH: Comparison of five PCR methods for detection of Helicobacter pylori DNA in gastric
tissues. J Clin Microbiol 1999, 37(3):772-774.
35.
Guo G, Jia KR, Shi Y, Liu XF, Liu KY, Qi W, Guo Y, Zhang WJ, Wang T, Xiao B: Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse. Stress 2009, 12(6):478-485.
36.
Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996, 20(10):1161-1181.